Zibtek

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Zenoti has hired several new execs over the past year, including Chief Financial Officer Sean Blitchok; Chief Customer Officer Steve Hudek; and Senior VP of Marketing Doug Sechrist. In 2023 it added Neal Singh, former chief operating officer at Icertis, as president and COO.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

Discover how Bytes Technology Group, a JSE-listed UK tech company, offers South African investors unique exposure to global digital transformation, cloud computing, and AI growth trends through its strategic partnerships with industry giants like Microsoft.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

Biotechnology innovations are revolutionizing healthcare with AI, data science, and automation, leading to more precise and personalized treatments.

Women's healthcare has long been underserved when it comes to technological innovation. While advancements in digital health have transformed diagnostics, disease management, and personalized medicine,

Is IonQ the quantum computing stock poised to dominate the AI landscape in 2025? This article explores IonQ's technology, potential applications, and investment considerations, offering insights into the future of quantum-enhanced AI.